These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 2621061)

  • 1. [Campylobacter pylori associated gastritis].
    Internist (Berl); 1989 Dec; 30(12):830-2. PubMed ID: 2621061
    [No Abstract]   [Full Text] [Related]  

  • 2. [Campylobacter pylori and therapy with bismuth salts].
    Börsch G
    Med Monatsschr Pharm; 1988 Sep; 11(9):301-7. PubMed ID: 3067064
    [No Abstract]   [Full Text] [Related]  

  • 3. [Electron microscopic findings during treatment of Campylobacter pylori-positive gastritis with bismuth salts].
    Rauws EA; Tytgat GN
    Z Gastroenterol; 1987 Sep; 25 Suppl 4():41-3. PubMed ID: 3687150
    [No Abstract]   [Full Text] [Related]  

  • 4. [Morphologic change in Campylobacter pylori associated gastritis in and following successful antibacterial therapy].
    Rühl GH; Börsch G
    Pathologe; 1989 Jan; 10(1):64-5. PubMed ID: 2922381
    [No Abstract]   [Full Text] [Related]  

  • 5. [What is safe in the treatment of Campylobacter pylori-induced gastritis and Campylobacter pylori-associated peptic ulcer?].
    Menge H
    Internist (Berl); 1988 Nov; 29(11):745-54. PubMed ID: 3069787
    [No Abstract]   [Full Text] [Related]  

  • 6. [Antibacterial treatment of Campylobacter pylori-associated gastritis and peptic ulcer].
    Andreasen JJ; Ringsdal VS
    Ugeskr Laeger; 1989 Apr; 151(17):1030-3. PubMed ID: 2734863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Campylobacter pylori: its link to gastritis and peptic ulcer disease.
    Marshall BJ
    Rev Infect Dis; 1990; 12 Suppl 1():S87-93. PubMed ID: 2406862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Therapy of peptic ulcer and chronic gastritis with bismuth salts].
    Rösch W
    Z Gastroenterol; 1987 Sep; 25 Suppl 4():34-40. PubMed ID: 3687149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The role of Campylobacter pyloridis in the etiology and pathogenesis of peptic ulcer].
    Loginov AS; Lorie NIu; Il'chenko AA; Radbil' OS
    Ter Arkh; 1988; 60(11):141-4. PubMed ID: 3070803
    [No Abstract]   [Full Text] [Related]  

  • 10. [Bismuth subsalicylate treatment in chronic Campylobacter pylori-associated erosive gastritis].
    Malfertheiner P; Stanescu A; Baczako K; Vanek E; Bode G; Ditschuneit H
    Dtsch Med Wochenschr; 1988 Jun; 113(23):923-9. PubMed ID: 3378501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Drug therapy of Campylobacter pylori-associated gastritis].
    Bielefeldt K
    Dtsch Med Wochenschr; 1988 Sep; 113(38):1495-6. PubMed ID: 3168772
    [No Abstract]   [Full Text] [Related]  

  • 12. [The role of Helicobacter pilori: reasons to believe it].
    Amouretti M
    Rev Prat; 1990 Feb; 40(4):339-40. PubMed ID: 2305196
    [No Abstract]   [Full Text] [Related]  

  • 13. The role of antibiotics in Campylobacter pylori associated peptic ulcer disease.
    Bayerdörffer E; Ottenjann R
    Scand J Gastroenterol Suppl; 1988; 142():93-100. PubMed ID: 3047854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Campylobacter pylori in chronic gastritis].
    Maaroos KhI
    Ter Arkh; 1989; 61(2):35-7. PubMed ID: 2727918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Bismuth--an environmental pollutant of the future].
    Mueller RL
    Zentralbl Hyg Umweltmed; 1989 Nov; 189(2):117-24. PubMed ID: 2604843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of bismuth subsalicylate on the histologic gastritis seen with Campylobacter pylori: a placebo-controlled, randomized study.
    Lanza FL; Skoglund ML; Rack MF; Yardley JH
    Am J Gastroenterol; 1989 Sep; 84(9):1060-4. PubMed ID: 2773899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A review of Campylobacter pylori in upper gastrointestinal disease.
    Walker SJ; Murray AE
    Br J Hosp Med; 1988 Jul; 40(1):27, 30-6. PubMed ID: 3048506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bacteriological and pharmacological basis for the treatment of Campylobacter pylori infection.
    McNulty CA
    Gastroenterol Clin Biol; 1989; 13(1 Pt 1):96B-100B. PubMed ID: 2663605
    [No Abstract]   [Full Text] [Related]  

  • 19. [Therapy of Campylobacter pylori infection].
    Börsch G
    Leber Magen Darm; 1988 Feb; 18(1):38-45. PubMed ID: 3280932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Chronic active surface-positive Campylobacter antrum gastritis-- morphological changes 1 year after treatment with bismuth].
    Sorf M; Krislo V; Gogora M
    Vnitr Lek; 1991; 37(9-10):768-71. PubMed ID: 1771809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.